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About 4-10% of the general population in the United States and 
Europe meet diagnostic criteria for depressive disorders using the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM IV) and International Statistical classifi cation of diseases and 
related health problems ( ICD-10) criteria.(7, 8) Depression is even more 
prevalent in patients with cardiovascular disease. Abundant evidence 
suggests that depression is under-recognized and under-treated in 
cardiac patients. Depression has been reported in about 20% of 
outpatients with coronary heart disease, 30- 40% of patients with heart 
failure,(9-11) and up to 50% of patients recently hospitalized for bypass 
surgery or acute coronary syndrome.(12) The prevalence of depression 
in patients with heart failure has varied in different studies. This is likely 
due to the use of different diagnostic instruments and the inclusion of 
different patient populations in terms of age, gender and disease 
severity.
The relationship between depression and heart failure is a relatively 
new but rapidly expanding area of interest in cardiology research. 
Because patients with heart failure face high rates of debilitation and 
mortality, the study of depression characteristics in this population is a 
critical research area in the pursuit of improved quantity and quality of 
their lives.(13-15) Depression may even be associated with the 
development of heart failure. For example, in the Systolic Hypertension 
in the Elderly Program (SHEP Study), 16% of patients who were 
depressed developed heart failure compared to 7% in the non-
depressed group.(16) Depression remained an important variable after 
adjustments for traditional risk factors, confi rming an overall increased 
relative risk of 2.6. 
Why is depression common in heart failure?
The explanation for the elevated incidence of depression in heart 
failure is uncertain. Various genetic, pathophysiologic and psychosocial 
factors have been postulated. Recent studies have identifi ed the same 
genetic polymorphisms to be associated with the development of both 
depression and cardiovascular disease.(17) Gene-gene interactions as 
well gene-environment interactions have also been identifi ed.(18, 19) 
Some have attributed the markedly elevated prevalence of depression 
in patients with heart failure, to the fact that both heart failure and 
depression share similar pathophysiology.(20) Neurohumeral activation, 
alterations in cardiac autonomic tone, infl ammation, increased levels of 
circulating catecholamines, greater platelet activation and elevated 
levels of cytokines may all play a role in the development, progression 
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Heart failure is a common clinical entity. 
Because patients with heart failure face high rates of 
debilitation and mortality, the study of depression 
characteristics in this population is a critical research area 
in the pursuit of improved quantity and quality of their 
lives. Studies have shown that depression is common in 
heart failure and, interestingly, that both conditions share 
similar pathobiological mechanisms. Depression in heart 
failure is a serious co-morbidity. It is a strong predictor of 
short-term worsening of heart failure symptoms, a decline 
in health status, mortality and re-hospitalization, 
independent of baseline ventricular function and severity of 
cardiovascular disease. Depression remains poorly 
recognized and under-treated in heart failure. The presence 
of depression is not random. It is disproportionately 
diagnosed amongst patients who are female, those suffering 
more advanced disease, those who are socially isolated and 
those of low socioeconomic status. Patients should be 
screened regularly for symptoms of depression. Although 
effective treatment is available, no studies have been done 
to show that treatment of depression has a positive impact 
on heart failure outcome.
ABSTRACT
Research conducted over the last two decades has provided strong 
evidence for an association between depression and the incidence of 
coronary artery disease,(1, 2) between depression and premature 
mortality among patients with documented coronary artery disease (3, 4) 
and between depression and all-cause mortality in populations with 
and without coronary artery disease.(5) The recent INTERHEART study 
confi rmed that psychosocial factors were stronger risk factors for 
myocardial infarction than diabetes, smoking, hypertension and obesity.(6) 
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and outcomes in heart failure.(12) Each of these pathophysiological 
states has also been seen in depression.(21-23) Psychosocial factors, such 
as stressful life events, have been shown to precipitate depression. Also, 
depression-generating stressors such as the threat of death and loss of 
autonomy that accompanies heart failure can precipitate depression. 
Depression increases morbidity and mortality in heart failure
Depression in patients with heart failure is a strong predictor of short-
term worsening of heart failure symptoms, a decline in health status, 
and mortality and re-hospitalization, independent of baseline ventricular 
function and severity of cardiovascular disease.(11, 24,  25) A link between 
depressive symptoms and the course of heart failure may be expected, 
because depressed individuals have elevated sympathoadrenal 
activation, a response that may be deleterious for patients with heart 
failure.(26, 27) Jiang et al. found that mortality and repeat hospitalization 
for decompensated heart failure, was 2.5 times higher in heart failure 
patients with major depression than in those without depression.(11) 
The incidence of repeat hospitalization followed a similar pattern. 
Depression is associated with medical non-compliance, a higher 
prevalence of smoking, and lower levels of social support, each of which 
have been correlated with negative outcomes in patients with heart 
failure.(20)
Depression is under-diagnosed in heart failure
Although addressing depression in heart failure patients provides a 
prime opportunity to really improve the patient’s quality of life, heart 
failure patients are not often treated for depression. Depression 
commonly is undiagnosed. Physicians may not address depression 
because they have not been adequately trained to recognize both 
typical and atypical depressive symptoms because of time constraints 
or because they don’t know how to best treat the condition. In addition, 
patients may be unwilling to disclose feelings of depression in order to 
avoid being stigmatized with the label of mental illness. The poor 
recognition rate of depression might be partly explained by the 
symptom overlap of the two disorders. These include fatigue, loss of 
energy, poor appetite, sleep disturbance, psychomotor agitation/
retardation and concentration defi cit.(28) Due to substantial overlap of 
somatic symptoms between depressive disorders and heart failure, 
depression may often be dismissed as the somatic symptom burden of 
heart failure. In order to improve the diagnosis of depression in heart 
failure patients, an awareness of the specifi c symptom profi le of 
depression as presented in heart failure patients is necessary. One 
study compared depression symptoms in depressed patients with and 
without heart failure.(29) This study found no difference between 
patients with regard to somatic symptoms of depression such as sleep 
disturbance, change in appetite, poor concentration and psychomotor 
agitation/retardation. However, they did fi nd that depressed patients 
without heart failure experienced more cognitive-emotional symptoms 
related to depression compared to depressed patients with heart 
failure. These symptoms included a sense of hopelessness and feelings 
of worthlessness or guilt. Similar fi ndings were confi rmed in two other 
studies.(28, 30)
This fi nding may partially explain the lower recognition rate of 
depression in patients with heart failure. Given their specifi c depression 
profi le, heart failure patients might report fewer feelings of depression, 
hopelessness, worthlessness and guilt in their medical history, so that 
their clinicians may not consider the presence of a depressive co-
morbidity. It has been suggested that patients with medical conditions 
may attribute their depression to their physical illness as an external, 
non-controllable factor. This might prevent these patients from self- 
reproaches, feelings of worthlessness and guilt. Recent studies have also 
confi rmed that depression prevalence is unrelated to the etiology of 
heart failure.(31, 32) 
The presence of depression in patients with heart failure can be 
assessed in the outpatient scenario by the use of rating scales such as 
the 9-Item Patient Health Questionnaire (PHQ-9).(33) The following 
should alert the physician to the presence of possible depression: the 
symptom burden is out of keeping with the objective measures of 
heart failure severity; heart failure remains stable, but the symptom 
burden increases; or the patient does not complain of anything or even 
hardly talks anymore. All of the above can be an indication that the 
patient simply is not well. The PHQ-9 is a self-report questionnaire that 
patients can fi ll out in the waiting room, taking less than 2 minutes to 
complete (see Figure 1). If the patient scores 10 or higher, this has a 
FIGURE 1: The 9-item Patient Health Questionnaire Depression Screening 
Instrument.(33)
1.  Little interest or pleasure in doing things 0 1 2 3 
2. Feeling down, depressed, or hopeless 0 1 2 3 
3.  Trouble falling or staying asleep, or 0 1 2 3
 sleeping too much      
4.  Feeling tired or having little energy 0 1 2 3
5.  Poor appetite or overeating  0 1 2 3
6.  Feeling bad about yourself - or that you  0 1 2 3
 are a failure or have let your family down    
7.  Trouble concentrating on things, such as  0 1 2 3
 reading the newspaper or watching television   
8. Moving or speaking so slowly that other people  0 1 2 3
 could have noticed. Or the opposite - being so 
 fi dgety or restless that you have been moving 
 around a lot more than usual     
9. Thoughts that you would be better off  0 1 2 3
 dead or of hurting yourself in some way     
 Add columns                                   Total
   Not Several More Nearly
   at all days than every
     half the day
     days
Over the last 2 weeks, how often have you been bothered by any of the following problems?
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90% specifi city and high positive predictive value, making it a good 
screening test to identify those at risk for depression. These patients 
should be referred to a psychiatrist to confi rm the diagnosis. If there are 
time constraints, patients can complete a 2-item screen, which takes 
less than a minute to complete.(34) Patients should have a follow-up 
clinical interview for depression if an affi rmative answer is given to 
either of two following questions:
 During the past month, have you often been bothered by feeling 
down, depressed or hopeless?
 During the past month, have you been bothered by little interest or 
pleasure in doing things?
In assessing patients, it is important to remember that some medication, 
such as corticosteroids, opioids and benzodiazepines, can induce 
depression. In a meta-analysis of 15 trials involving more than 35 000 
cardiac patients, the absolute annual increase in risk of reported 
depressive symptoms was 6 per 1 000 patients which, contrary to 
popular belief, was not signifi cant.(35) 
Predictors of the onset of depressive symptoms in heart 
failure patients
A greater awareness of which heart failure patients may be at increased 
risk for the development of depression, may aid in earlier diagnosis 
and intervention. The presence of depression is not random. It is 
disproportionately diagnosed amongst patients who are female, those 
suffering more advanced disease, those who are socially isolated and 
those of low socioeconomic status.(29) Certain psychosocial factors may 
contribute to the high prevalence of depression. These include medical 
non-compliance, high prevalence of smoking and lower levels of social 
support, each of which has been correlated with worse outcomes in 
heart failure.(20) 
One study evaluated the factors associated with the onset of depression 
in patients with heart failure.(36) This study used the Medical Outcome 
Study – Depression questionnaire (MOS-D), a screening tool used in 
case-fi nding studies of depression.(37) Patients also completed the 
Kansas City Cardiomyopathy Questionnaire (KCCQ), which is a 
23-item, disease specifi c, health status instrument for patients with 
heart failure. The KCCQ measures symptoms, physical functioning, 
social functioning, self-effi cacy and quality of life. The KCCQ has been 
shown to predict mortality and cardiac events, such as hospitalization in 
heart failure patients.(24, 38, 39) In a multivariate analysis, the study showed 
that living alone, alcohol abuse, the perception that medical care has 
been a substantial economic burden and health status, as measured by 
the KCCQ, were independent predictors of developing depressive 
symptoms. 
■
■
For patients without these factors, about 8% developed depression by 
one year of follow-up in the study. At one year, 16%, 36% and 69% of 
those with one, two or three of these risk factors, respectively, developed 
depression. There was also a gradient relationship between poor health 
status and increased risk of developing depression. The authors 
concluded that social factors and health status are predictive of the risk 
of development of depression in outpatients with heart failure. Clinicians 
should be aware of which patients are at risk for the development of 
depression, so that these patients can be screened and evaluated more 
fully. Since 8% of those without any of these risk factors developed 
depression over the ensuing year, clinicians should screen patients 
regularly over time for depression.(36)
Gottlieb et al. demonstrated that depression was more common in 
younger patients with heart failure.(40) Depression was also more 
commonly reported in women than in men. Depressed patients scored 
signifi cantly worse than non-depressed patients on all components of 
questionnaires measuring quality of life. However, they did not differ in 
ejection fraction or treatment, except that depressed patients were 
signifi cantly less likely to be receiving beta-blockers. 
Treatment of depression in heart failure
Effi cacious treatments for depression are still lacking, despite the 
development of state-of-the-art pharmacotherapy. A substantial patient 
population does not respond to treatment and / or maintains clinically 
signifi cant symptoms despite treatment attempts.(41) Responsiveness 
may itself have prognostic importance.(42) Studies describing depression 
treatments among heart failure patients rely on too small and 
heterogeneous samples to permit defi nitive conclusions regarding 
intervention effectiveness. No studies have, to date, investigated the 
effects of depression intervention on objective clinical outcomes such 
as survival or secondary cardiac events in a heart failure population. 
Despite these limitations, a general pattern of decreased depressive 
symptoms and increased physical activities, as measured by the standard 
6-minute walk test, has been observed across the treatment studies. 
When discussing treatment with patients, it is important to emphasise 
the biological etiology of depression, because many patients see 
depression as a character weakness or personality fl aw. Social stigma 
against mental health diagnoses can make patients reluctant to 
acknowledge and report depressive symptoms. It may also be helpful 
to inform patients that depression is very common, affecting 1 out of 5 
patients with heart disease. An experienced clinical psychologist can 
administer cognitive behavioral therapy, which helps patients develop 
new ways of thinking and behaving, minimizing symptoms of depression. 
The addition of interpersonal and problem-solving therapy can also be 
effective in treating depression.(43) Interpersonal therapy addresses 
social and interpersonal stress that can contribute to depression, whilst 
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problem-solving therapy helps patients identify specifi c problems that 
may be contributing to their depression.
Pharmacotherapy for depression
As far as pharmacotherapy is concerned, little is known about treatment 
options for depression in patients with heart failure. The selective 
serotonin reuptake inhibitors (SSRI), such as sertraline, are safe and 
effective medication for treating depression in patients with heart 
disease such as acute coronary syndrome.(44) Drugs such as citalopram 
and sertraline are the least likely to inhibit cytochrome p-450 enzymes, 
thus minimizing exposure to pharmacokinetic interactions in cardiac 
patients taking multiple drugs.(45)
It is important that the dose of these drugs should be modifi ed in 
elderly patients or in those with hepatic or renal disease. If the patient 
does not respond to one SSRI at an optimal therapeutic dose, an 
alternative one should be prescribed. Most commonly recorded side 
effects of these agents include insomnia or somnolence, nausea, 
diarrhoea and sexual dysfunction. Most of these effects disappear within 
the fi rst month of treatment, so it is important to encourage the patient 
to continue with the medication. However, sexual dysfunction occurs in 
about 60% of patients treated with SSRIs and is the least likely adverse 
effect to resolve over time.(46) Some patients with SSRI-induced sexual 
dysfunction derive benefi t from sildenafi l.(47)
Other antidepressant medication such as mirtazapine is generally safe 
for patients with heart disease, but not as fi rst-line therapy, as it is 
associated with weight gain.(48) Tricyclic agents should not be used as 
fi rst-line, because of their association with adverse cardiovascular 
events.(49) 
In managing depression in heart failure, it is important to know which 
patients need to be referred to a psychiatrist. Patients who report 
manic symptoms, delusions or hallucinations and those who have 
suicidal thoughts, should be referred for further evaluation. Once 
pharmacotherapy has been instituted, the patient should be advised 
that it would take at least four weeks to feel better, with the majority 
recovering after six months of treatment. Once the patient has 
responded to pharmacotherapy, treatment should be continued for at 
least another six to twelve months to avoid relapse. Once the decision 
has been made to discontinue drug therapy, it should be weaned over 
a period of time. 
Palliative care in patients with heart failure
Spiritual well-being, an important coping resource in patients with 
terminal cancer, is associated with less depression. This relationship has 
only recently been studied in patients with heart failure. Spirituality is 
defi ned as “the way in which people understand their lives in view of 
their ultimate meaning and value.”(50) Bekelman et al. identifi ed the 
relationship between spiritual well-being and depression in an elderly 
heart failure population, in the context of other common risk factors 
for depression, including low social support, poor health status and 
number of physical symptoms.(52) 
In this study, greater inner peace was shown to be signifi cantly associated 
with less depression when adjusted for other variables such as better 
health status, fewer physical symptoms, gender and income, which were 
also associated with less depression. Whether enhancing a patient’s 
sense of meaning/peace might reduce or prevent depression and thus 
improve quality of life in patients with heart failure, has thus far been 
untested. One approach to address the multiple factors associated with 
depression and poor quality of life in heart failure patients may be the 
early incorporation of palliative care.(53, 54) Palliative care addresses 
spiritual well-being and may be an under-utilized resource in caring for 
patients with heart failure. 
CONCLUSIONS                                                                     
The increased prevalence of depression seen in patients with heart 
failure is now well established. What remains is to determine why this is 
the case, in the hope of eventually being able to target treatment at the 
true root of the problem. In the meantime, heart failure patients should 
be screened for depression and treated when depression is found to 
be present. This may help to improve the patient’s quality of life and 
potentially improve long-term outcomes. 
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